Baihua Pharmaceuticals: Jinhua State-owned Assets Supervision and Administration Commission invests 890 million yuan to acquire 20.68% of shares, becoming the company's new actual controller.

Recently, Baihua Pharmaceutical issued an announcement stating that the company’s controlling shareholder and actual controller, Mi Zaiqi, Mi Enhua, Yang Xiaoling, and Jinhua Juxin Enterprise Management Partnership Enterprise, signed a “Share Transfer Agreement.”

Under the agreement, Mi Zaiqi, Mi Enhua, and Yang Xiaoling intend to transfer a total of 79.53 million shares of the company’s unrestricted tradable shares they hold (representing 20.68% of the company’s total share capital) to Jinhua Juxin. The total consideration for the transfer is RMB 890 million, which is equivalent to RMB 11.19 per share.

After this share transfer, Jinhua Juxin will hold 79.53 million shares of the company, accounting for 20.68% of the company’s total share capital, while Mi Zaiqi, Mi Enhua, and Yang Xiaoling will no longer hold any shares of the company. The controlling shareholder will change from Mi Zaiqi, Mi Enhua, and Yang Xiaoling to Jinhua Juxin, and the actual controller will change to the Jinhua Municipal People’s Government State-owned Assets Supervision and Administration Commission.

To protect the interests of investors, the company’s stock will resume trading on April 8, 2026.

(Baihua Pharmaceutical announcement)

(Editor: Yang Yan Lin Chen)

Keywords:

                                                            Medical